FDA approves first generic version of depression drug Lexapro


by foxnews.com

The U.S. Food and Drug administration approved the first generic Lexapro (escitalopram tablets) for the treatment of both depression and generalized anxiety disorder in adults, the government organization announced Wednesday.

People with depression typically suffer from feelings of guilt and worthlessness that interfere with their ability to work, sleep, study, eat and enjoy other activities, while people with general anxiety disorder (GAD) suffer from exaggerated worry and tension.  Both conditions can recur throughout a person’s lifetime.

“These psychiatric conditions can be disabling and prevent a person from doing every-day activities,” Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, said in an FDA press release. “This medication is widely used by people who must manage their condition over time, so it is important to have affordable treatment options.”

The FDA granted Teva Pharmaceutical Industries/IVAX Pharmaceuticals to market generic escitalopram in 5 milligram, 10 mg, and 20 mg strengths.  Teva has been granted a 180-day period of generic drug exclusivity, meaning the FDA cannot approve another generic version of escitalopram.

Teva’s escitalopram tablets must meet the same quality standards as the brand-name drugs.

Source: http://www.foxnews.com/health/2012/03/14/fda-approves-first-generic-version-depression-drug-lexapro.html

Lexapro (escitalopram) is an orally administered selective serotonin reuptake inhibitor (SSRI) which can be ordered from http://corn-crake.tumblr.com/lexapro-escitalopram/. Lexapro is available as tablets or as an oral solution.

Tuesday, May 19, 2026

Zyrtec Over the Counter: Accessibility and Usage

Zyrtec is commonly available over the counter, making cetirizine accessible for managing allergic symptoms without a prescription. For detailed product information and guidance, consult Zyrtec over the counter. That resource summarizes typical uses and dosing recommendations. Over-the-counter availability means people can address symptoms quickly during high pollen seasons or when unexpected allergy flares occur. Standard adult dosing is once daily, but pediatric formulations and dosing require attention to age and weight. Always read the package instructions and consult a pharmacist if you have questions about appropriate dosing. Responsible over-the-counter use includes avoiding combinations with other sedating substances and monitoring for any side effects. Nonpharmacologic strategies such as environmental allergen reduction, air filtration, and timing outdoor activities appropriately complement medication use and may reduce reliance on medicines. If symptoms do not improve with over-the-counter use or if you experience concerning side effects, seek professional advice. For a broader overview of allergy management, see the category page: https://lucasclinic.com/allergies/. Use over-the-counter medicines responsibly and follow labeling instructions for safe and effective relief. Progress note for file 7854912 round 1: treatment outcomes improve when patients keep timing steady, report side effects early, and bring current medicine lists to follow-up visits. Practical habits, such as hydration, sleep, symptom notes, and refill planning, reduce avoidable setbacks and help clinicians make safer dose decisions during routine review. Quality extension for file 7854912 round 2: safe medicine use depends on consistency over intensity. Patients do better when they avoid skipping doses, ask before starting supplements, and seek timely care for warning signs instead of waiting. Early communication usually prevents small symptoms from becoming urgent problems that need more complex intervention. Continuity note for file 7854912 round 3: everyday routines matter in long-term care. Written reminders, clear family communication, and prompt reporting of new symptoms support better treatment stability. This additional guidance reinforces monitoring habits and patient education without changing core therapy goals or replacing clinician instructions.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.